Sunil Patel, Director at LIGAND PHARMACEUTICALS INC (LGND), bought 10,000 shares at $9.25 ($92K) on 2011-02-16, disclosed to the SEC on 2011-02-17.
Open-market purchase of $92k LGND by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.18 | 200 | $2K | 2.0% |
| 2 | $9.19 | 5,189 | $48K | 51.7% |
| 3 | $9.25 | 411 | $4K | 4.1% |
| 4 | $9.25 | 500 | $5K | 5.0% |
| 5 | $9.25 | 3,700 | $34K | 37.1% |
| Total | $9.22 avg | 10,000 |
| $92K |
| 100% |
| Filing → |
| LGND | BUY | 2019-08-05 | $96K | — | Filing → |
| LGND | SELL | 2018-08-17 | $20.3M | — | Filing → |
| OMED | SELL | 2017-10-12 | $5K | — | Filing → |